Jeena Sikho Lifecare Incorporates 60% Owned Subsidiary Ayugenomics
Jeena Sikho Lifecare Ltd · Others (Uncategorized) · 11 Nov 2026, 11:12 pm
Jeena Sikho Lifecare Incorporates 60% Owned Subsidiary Ayugenomics Jeena Sikho Lifecare Limited incorporated a new subsidiary, Ayugenomics Private Limited, on 11th Nov'26 in India. The company subscribed to a 60% equity stake comprising 30,000 shares of ₹10 each for a total cash consideration of ₹3,00,000 at face value. Ayugenomics will focus on R&D, diagnostics, genomics-based panels, AI platforms, and clinical services integrating genomics with Ayurveda and AYUSH systems. It plans to commercialize evidence-based herbal products, pursue domestic and global regulatory approvals including US FDA, and target markets like Japan.
Original exchange filing (PDF)
More announcements from Jeena Sikho Lifecare Ltd
- Submission of audio recording of Earnings Conference Call - Q2 FY 2026-27 · 16 Nov 2026
- Submission of Investor Presentation · 16 Nov 2026
- Jeena Sikho Lifecare Limited has submitted to the Exchange, Outcome of the Meeting of the Board of Directors of Jeena Sikho Lifecare Limited held on November 14, 2026 for the declaration of Unaudited financial results (Standalone and Consolidated) for the period ended September 30, 2026. · 15 Nov 2026
- Declaration of Unaudited Financial Results (Standalone & Consolidated) for Quarter and Half year ended 30.09.2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended 30.09.2026 · 15 Nov 2026
- Intimation of Schedule of Analyst / Investor Meet/ Conference under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 13 Nov 2026
- Launch of New Products · 11 Nov 2026
- Intimation of Earnings Conference Call for Investors and Analysts for Q2 FY26-27 Financial Results · 16 Nov 2026
